Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review
Author:
Aveta Achille12ORCID, Iossa Vincenzo23, Spena Gianluca4ORCID, Conforti Paolo1, Pagano Giovanni1, Dinacci Fabrizio1, Verze Paolo5, Manfredi Celeste6ORCID, Ferro Matteo7, Lasorsa Francesco8ORCID, Spirito Lorenzo6, Napolitano Luigi1ORCID, Tufano Antonio4, Fiorenza Alessandra1, Russo Pierluigi9ORCID, Crocerossa Fabio10ORCID, Lucarelli Giuseppe8ORCID, Perdonà Sisto4, Sanseverino Roberto2, Siracusano Salvatore3, Cilio Simone1ORCID, Pandolfo Savio Domenico135ORCID
Affiliation:
1. Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples “Federico II”, 80131 Naples, Italy 2. Department of Urology, Umberto I Hospital, ASL Salerno, 84014 Nocera Inferiore, Italy 3. Department of Urology, University of L’Aquila, 67100 L’Aquila, Italy 4. Department of Urology, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, 80131 Naples, Italy 5. Department of Medicine and Surgery, Scuola Medica Salernitana, University of Salerno, 84081 Fisciano, Italy 6. Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy 7. Division of Urology, European Institute of Oncology, IRCCS, 71013 Milan, Italy 8. Department of Precision and Regenerative Medicine and Ionian Area-Urology, Andrology and Kidney Transplantation Unit, University of Bari “Aldo Moro”, 70124 Bari, Italy 9. Department of Urology, Fondazione Policlinico Universitario Agostino Gemelli, Largo Francesco Vito 1, 00168 Rome, Italy 10. Division of Urology, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy
Abstract
This review focuses on ablative techniques for small renal masses (SRMs), including radiofrequency ablation (RFA), cryoablation (CA), microwave ablation (MWA), and irreversible electroporation (IRE), and discusses recurrence management. Through an extensive literature review, we outline the procedures, outcomes, and follow-up strategies associated with each ablative method. The review provides a detailed examination of these techniques—RFA, CA, MWA, and IRE—elucidating their respective outcomes. Recurrence rates vary among them, with RFA and CA showing comparable rates, MWA demonstrating favorable short-term results, and IRE exhibiting promise in experimental stages. For managing recurrences, various strategies are considered, including active surveillance, re-ablation, or salvage surgery. Surveillance is preferred post-RFA and post-CA, due to slow SRM growth, while re-ablation, particularly with RFA and CA, is deemed feasible without additional complications. Salvage surgery emerges as a viable option for larger or resistant tumors. While ablative techniques offer short-term results comparable to surgery, further research is essential to understand their long-term effects fully. Decisions concerning recurrence management should consider individual and tumor-specific factors. Imaging, notably contrast-enhanced ultrasounds, plays a pivotal role in assessing treatment success, emphasizing the necessity of a multidisciplinary approach for optimal outcomes. The lack of randomized trials highlights the need for further research.
Reference94 articles.
1. Epidemiology of Renal Cell Carcinoma: 2022 Update;Bukavina;Eur. Urol.,2022 2. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update;Ljungberg;Eur. Urol.,2022 3. Calace, F.P., Napolitano, L., Arcaniolo, D., Stizzo, M., Barone, B., Crocetto, F., Olivetta, M., Amicuzi, U., Cirillo, L., and Rubinacci, A. (2022). Micro-Ultrasound in the Diagnosis and Staging of Prostate and Bladder Cancer: A Comprehensive Review. Medicina, 58. 4. Lasorsa, F., Rutigliano, M., Milella, M., Ferro, M., Pandolfo, S.D., Crocetto, F., Autorino, R., Battaglia, M., Ditonno, P., and Lucarelli, G. (2023). Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers. Int. J. Mol. Sci., 24. 5. Lasorsa, F., Rutigliano, M., Milella, M., Ferro, M., Pandolfo, S.D., Crocetto, F., Simone, S., Gesualdo, L., Battaglia, M., and Ditonno, P. (2023). Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma. Int. J. Mol. Sci., 24.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|